Manufacture of peanut formulations for oral desensitization
US11141352B2 · kind B2 · utility
3Cited by
7References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 26, 2019 |
| Grant date | Oct 12, 2021 |
| Priority date | — |
| Expiry date | Jun 26, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/542
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.